Stop EpiPen Profiteering: Drop the price of this lifesaving medicine NOW!
Heather Bresch, CEO, Mylan Pharmaceuticals
Update: Mylan has now responded to consumer outrage with a claim that they’re cutting EpiPen's price in half. But this is pure corporate spin. The price cuts only apply to some underinsured consumers, who will get a $300 savings card. Everyone else, including anyone receiving Medicare or Medicaid, continues to pay the outrageous $600 price tag.
To:
Heather Bresch, CEO, Mylan Pharmaceuticals
From:
[Your Name]
The EpiPen contains only $1 worth of medicine, but you're charging hundreds of times that amount. How many poor children will die because their parents can’t afford $600 EpiPens? Drop the price of this lifesaving medicine NOW!